REQUEST A DEMO
Total
USD $0.00
Search more companies

Cardinal Health Singapore 225 Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmaceutical and Medicine Manufacturing
Full name: Cardinal Health Singapore 225 Pte. Ltd. Profile Updated: August 29, 2019
Buy our report for this company USD 19.99 Most recent financial data: 2018 Available in: English Download a sample report

Cardinal Health Singapore 225 Pte. Ltd. is engaged in providing pharmaceuticals, specialty plasma products and value-added services to healthcare providers and pharmaceutical manufacturers. The company distributes its products to nuclear pharmacies and hospitals. Cardinal Health Singapore 225 Pte. Ltd. operates as subsidiary of Cardinal Health from Dublin, Ireland.

Headquarters
8 Marina Boulevard #05-02 Marina Bay Financial Centre Singapore 018981
Singapore; Singapore; Postal Code: 018981

Contact Details: Purchase the Cardinal Health Singapore 225 Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Cardinal Health Singapore 225 Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Cardinal Health Singapore 225 Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Cardinal Health Singapore 225 Pte. Ltd. report to view the information.
Incorporation Date:
January 12, 2004
Key Executives
Purchase this report to view the information.
Chairman/Director
Purchase this report to view the information.
Chairman/Director
Purchase this report to view the information.
Chairman/Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
Subsidiaries
Almus Pharmaceuticals Singapore Pte. Ltd.
Company Performance
Financial values in the chart are available after Cardinal Health Singapore 225 Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Total operating revenue
29.92%
Net Profit (Loss) for the Period
54.08%
Total assets
-30.16%
Total equity
-50.25%
Return on Equity (ROE)
22.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?